T-20

ASHM 2006: Strategies for coping with multiple drug resistance

Finding effective treatment options for people who have taken many treatments and have multiple resistance mutations continues to be a significant challenge for HIV clinicians, and their patients.

Time to deliver

The 16th International AIDS Conference highlighted numerous important and promising developments in HIV treatments. JOHN DAYE reports.

Advice on T-20 and international travel

travelling with HIV Following the recent terrorist alert in the UK, new rules prevent passengers on many international flights carrying liquids in their hand luggage. Read this article for advice on travelling with T-20 under the new rules.

The T-20 conundrum

 What is the place of T-20 in the spectrum of HIV treatment, and when is the best time to start treatment on T-20? These were among the questions considered at a meeting in Sydney on Saturday 8 April.

One Day

Not all my days are the same, but Thursday is the day I do my volunteer work for PLWHA NSW, something I look forward to each week. Going into the office makes me feel good, it gives me purpose and motivation, and allows me to enter an environment that I always find welcoming, friendly and rewarding.

Travelling with needles and syringes

When travelling with Fuzeon® (T20), check with the consulate of the country that you’re visiting about their laws on needles and syringes. It may sometimes be easier to post them ahead and only carry what you need to inject on your journey. It also pays to check with the airline about carrying syringes and needles on board their aircraft. If possible you may prefer to schedule your injections so that you don’t have to inject on board a plane.

News and treatments briefs

 HIV-related news in brief from the June-July 2005 edition of Positive Living.

Rescue me

What are the options when you’re running out of options?

Never say never

The fusion inhibitor T-20 is presents some special challenges when travelling. Bernie Slagtman shares his tips for taking T-20 on the road.

A tale of two cities

With major medical conferences in the United States and Scotland, November was a busy month for HIV medicine. PAUL KIDD reviews some key findings.